
Robert Molander
CCO
Infant Bacterial Therapeutics
Robert has over 25 years of experience working in life science organizations with launching and commercializing pharmaceuticals in the United States at organizations such as Pfizer and Novartis. He has also served as an Executive Council Member at the Harvard Medical School. Robert holds an MBA from Washington University and bachelor’s degrees from Miami University in Economics and International Studies.